Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.
Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
July 2014—Horizon Discovery entered into a nonexclusive license agreement with the Broad Institute to access intellectual property related to the CRISPR/Cas9 gene-editing system. Under the terms of the agreement, Horizon has rights to use the technology commercially for applications including development of research tools and reagents.
July 2014—Vermillion launched Aspira Labs, which will specialize in using a biomarker-based diagnostic algorithm to inform clinical decision-making and advance personalized treatment plans in the management of gynecologic cancers. The lab, based in Austin, Tex., will also serve as an education and resource hub for health care professionals and women facing surgery for ovarian masses that are potentially cancerous and other related gynecologic conditions.
July 2014—Leica Microsystems opened an Experience Lab in its Tokyo headquarters. The laboratory is dedicated to product demonstrations of Leica microscope systems and workshops. Additionally, it serves as a showroom for microscope users who wish to get to know the instruments and accessories, such as cameras, illumination, and software. Users can bring their own samples to observe with the systems and can take advantage of a sample preparation service for industrial samples to be observed and analyzed on site.
July 2014—BioView announced that the FDA cleared for marketing its automated scanning microscope and image analysis system, the Duet, to qualitatively detect rearrangements involving the ALK gene via fluorescence in situ hybridization in formalin-fixed, paraffin-embedded non-small cell lung cancer tissue specimens, probed with the Abbott Vysis ALK Break Apart FISH Probe Kit.
July 2014—Hologic’s Tomcat instrument performs a full range of sample processing activities for liquid-based cytology samples, from decapping and capping of sample tubes to vortexing, aliquoting, incubating, and racking of each sample. The fully automated instrument provides positive bar-code matching for each sample as well as reagent addition if desired. By eliminating repetitive manual steps, the instrument enhances workflow efficiency and reduces hands-on time, which minimizes the risk of cross-contamination.
July 2014—Biocare Medical expanded its automated instrumentation offering with the Oncore Automated Slide Staining System. The Oncore is a compact benchtop instrument that performs both immunohistochemistry and in situ hybridization tests on formalin-fixed, paraffin-embedded tissues.
July 2014—DeNovo Sciences published “A novel microchannel-based device to capture and analyze circulating tumor cells (CTCs) of breast cancer.” DeNovo’s scientific team explored microfluidic capture techniques for isolating CTCs, which resulted in the development of proprietary technology to accomplish rare cell capture and analysis.
July 2014—Wako Life Sciences’ µTasWako i30 is available for the serum biomarkers lectin-reactive alpha-fetoprotein (AFP-L3) and des-gamma-carboxy prothrombin (DCP) tests, which are intended for in vitro diagnostic use to help in the risk assessment of patients with chronic liver disease for development of hepatocellular carcinoma in conjunction with other laboratory findings, imaging studies, and clinical assessment.
July 2014—Designed to improve productivity and ensure sample safety and integrity, the Thermo Scientific Sorvall RC BIOS 10 centrifuge system accommodates a range of cell culture and bioprocessing applications. The company’s Fiberlite F5-10×1000 LEX carbon fiber rotor spins up to 10 one-liter Nalgene centrifuge bottles in a single run. The system’s large capacity and design suits numerous applications, including bacterial and mammalian cell pelleting, pelleting of cell cultures from fermentation tanks, large microbial cultures, biologics and vaccine production, clarifying broths, and harvesting cell and tissue cultures.
July 2014—Combining a tough exterior with smart printing capabilities, Brady’s BMP21-LAB handheld printer is designed for labeling slides, straws, dishware, bottles, vials, and tubes. The printer’s drop, lock, and print technology enables users to insert the label cartridge and start printing, with no setup required. The vial label shortcut key automatically cuts labels according to vial and tube sizes. Once the label is printed and cut, the grabber feature prevents it from falling to the ground.
